Complement Activation in the Lysosomal Storage Disorders
Condition(s):Fabry Disease; Gaucher Disease; Niemann-Pick Disease, Type C; Lysosomal Storage DiseasesLast Updated:June 7, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Fabry Disease; Gaucher Disease; Niemann-Pick Disease, Type C; Lysosomal Storage DiseasesLast Updated:June 7, 2021Withdrawn
Condition(s):Cardiopulmonary Bypass; Inflammatory Response; Platelet DysfunctionLast Updated:October 4, 2022Completed
Condition(s):Previous Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I DeficiencyLast Updated:April 8, 2022Terminated
Condition(s):Platelet StorageLast Updated:September 13, 2017Unknown status
Condition(s):Thrombotic Microangiopathies; Hemolytic Uremic Syndrome, Atypical; Hemolytic-Uremic SyndromeLast Updated:August 23, 2021Recruiting
Condition(s):Allografted With Myeloablative ConditioningLast Updated:April 10, 2015Completed
Condition(s):Organ Transplant RecipientsLast Updated:February 19, 2018Completed
Condition(s):Complement Mediated DiseasesLast Updated:January 16, 2018Completed
Condition(s):Acute AppendicitisLast Updated:March 1, 2018Completed
Condition(s):Fetal LossesLast Updated:October 15, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.